Billing itself as the first AI biotech to launch human trials, Recursion adds $121M C round

Billing itself as the first AI biotech to launch human trials, Recursion adds $121M C round

Source: 
Endpoints
snippet: 

Billing itself as the first AI biotech with programs in the clinic, Salt Lake City-based Recursion now has a $121 million bankroll to start gathering human data to see if it’s on the right track.